ROBERT PICKERAL: Open Payments
NPI 1205469186 · WATERTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 22 payments from 11 companies in 2025. Trend: 2023 $740 · 2024 $1,021 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $200 |
| AstraZeneca Pharmaceuticals LP | 4 | $161 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Madrigal Pharmaceuticals | 1 | $35 |
| Phathom Pharmaceuticals, Inc. | 3 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
Products named: AIRSUPRA, Wegovy, REZDIFFRA, VOQUEZNA, Rybelsus, GEMTESA, OTEZLA, XIFAXAN.
Industry payments across NY — which companies pay providers there.
